News from WCM

New research shows that youth who become increasingly addicted to social media, mobile phones or video games are...

Dr. Teresa Sanchez, associate professor of pathology and laboratory medicine and associate professor of neuroscience in the Feil Family Brain and Mind Research Institute at Weill Cornell Medicine, has been awarded the highly competitive Established Investigator Award from the American Heart Association.

 A study led by Weill Cornell Medicine investigators has found that immune tolerance to gut microbes depends on an ancient bacterial-sensing protein called STING—normally considered a trigger for inflammation. 

Using an algorithm they call the Krakencoder, researchers at Weill Cornell Medicine are a step closer to unraveling how the brain’s wiring supports how we think and act.

At the 12th annual Helen and Robert Appel Alzheimer’s Disease Research Institute Symposium, scientists and clinicians shared their latest research which is advancing how Alzheimer’s disease is diagnosed and treated. 

A large prospective, randomized clinical trial in patients with advanced breast cancer has found that the use of liquid biopsy blood tests for early detection of a treatment-resistance mutation, followed by a switch to a new type of treatment, substantially extends the period of tumor control compared to standard care.

A new study from researchers at Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center (MSK) provides fresh insights about how cancers evolve when they metastasize — insights that could aid in developing strategies to improve the effectiveness of treatment.

Dr. Arnab Ghosh, assistant professor of medicine at Weill Cornell Medicine, has been selected as an Emerging Leader in Health and Medicine Scholar.

Researchers from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center are expanding the understanding of how the BCG treatment for early bladder cancer works.

Four Weill Cornell Medicine investigators received the Ritu Banga Healthcare Disparities Research Awards, recognizing innovative research that will help close care gaps in clinical settings.

Researchers at Weill Cornell Medicine have discovered how a parasite that causes malaria when transmitted through a mosquito bite can hide from the body’s immune system, for years sometimes.

On May 15, Weill Cornell Medicine honored Class of 2025 graduates from Weill Cornell Medical College and the Weill Cornell Graduate School.

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical trial led by an investigator at Weill Cornell Medicine and NewYork-Presbyterian that compared the safety and efficacy of the injectable drugs. 

A new artificial intelligence-based method accurately sorts cancer patients into groups that have similar characteristics before treatment and similar outcomes after treatment, according to a study led by investigators at Weill Cornell Medicine.

Weill Cornell Medicine-Qatar awarded Cornell University medical degrees to 45 new doctors during the institution’s commencement ceremony May 7.

Weill Cornell Medicine has received a projected $4 million grant from the National Cancer Institute, part of the National Institutes of Health, to conduct a clinical trial testing whether a new imaging approach could reduce the need for biopsies to monitor prostate cancer.

Using machine learning technology, a new study has identified three distinct profiles describing social and economic factors that are associated with a higher risk of suicide.

A tiny chemical modification commonly found on messenger RNAs plays a surprisingly large role in how cells respond to stress, according to a study led by Weill Cornell Medicine investigators.

More than 170 Weill Cornell Medicine leaders, donors, students and alumni gathered May 1 to celebrate the completion of the institution’s new $260 million student residence—and the reveal of its official name.

The Griffis Faculty Club buzzed with excitement as doctoral students from the Weill Cornell Graduate School of Medical Sciences presented their research, drawing peers, faculty and alumni to the 44th annual Vincent du Vigneaud Symposium on April 24.